{{Rsnum
|rsid=1867561
|Gene=ST6GALNAC2
|Chromosome=17
|position=76585943
|Orientation=plus
|GMAF=0.2264
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=ST6GALNAC2
}}{{PharmGKB
|RSID=rs1867561
|Name_s=ST6GALNAC2:c.-135C>G
|Gene_s=ST6GALNAC2
|Feature=
|Evidence=PubMed ID:17480010
|Annotation=This promoter variant is a tagging SNP for ADG haplotype which confers significantly reduced promoter activity and susceptability to IgA Nephropathy.
|Drugs=
|Drug Classes=
|Diseases=Glomerulonephritis, IGA
|Curation Level=Curated
|PharmGKB Accession ID=PA161615725
}}{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1867561
|overall_frequency_n=3
|overall_frequency_d=4
|overall_frequency=0.75
|n_genomes=4
|n_genomes_annotated=0
|n_haplomes=6
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}